Want to see GB:CNSL full AI Analyst Report?
Omega Diagnostics (CNSL) Ratios
Omega Diagnostics Ratios
GB:CNSL's free cash flow for Q4 2025 was $-470.00K. For the 2025 fiscal year, GB:CNSL's free cash flow was decreased by $-70.00K and operating cash flow was $-400.00K. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.40 | 3.62 | 4.67 | 4.29 | 3.12 |
| Quick Ratio | 3.00 | 3.23 | 4.31 | 3.89 | 2.80 |
| Cash Ratio | 1.59 | 2.30 | 1.74 | 2.64 | 0.47 |
| Solvency Ratio | -2.93 | 0.91 | 0.08 | -0.73 | -1.79 |
| Operating Cash Flow Ratio | -0.68 | 0.04 | 0.36 | -1.63 | -0.94 |
| Short-Term Operating Cash Flow Coverage | -11.34 | 0.00 | 4.93 | -57.31 | -10.91 |
| Net Current Asset Value | $ 3.88M | $ 5.27M | $ 3.66M | $ 3.84M | $ 4.72M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.03 | 0.01 | 0.01 | 0.02 |
| Debt-to-Equity Ratio | 0.02 | 0.03 | 0.02 | 0.01 | 0.03 |
| Debt-to-Capital Ratio | 0.02 | 0.03 | 0.02 | 0.01 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.21 | 1.44 | 1.45 | 1.51 |
| Debt Service Coverage Ratio | -15.91 | 129.29 | 2.37 | -37.76 | -2.65 |
| Interest Coverage Ratio | -80.38 | -37.65 | -24.32 | -213.77 | -27.71 |
| Debt to Market Cap | 0.02 | 0.00 | 0.02 | 0.01 | 0.04 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 6.41 | -2.06 | 38.29 | 1.90 | 3.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.32% | 60.08% | 61.86% | 42.05% | 55.62% |
| EBIT Margin | -14.98% | 19.00% | -7.40% | -42.92% | -10.88% |
| EBITDA Margin | -5.62% | 26.39% | -0.75% | -35.09% | -4.47% |
| Operating Profit Margin | -14.98% | -7.68% | -5.47% | -36.83% | -6.82% |
| Pretax Profit Margin | -63.37% | 18.80% | -7.62% | -43.10% | -11.13% |
| Net Profit Margin | -83.53% | 18.80% | -3.36% | -51.15% | -132.72% |
| Continuous Operations Profit Margin | -83.53% | 18.80% | -3.36% | -42.04% | -16.50% |
| Net Income Per EBT | 131.81% | 100.00% | 44.03% | 118.70% | 1192.95% |
| EBT Per EBIT | 422.97% | -244.69% | 139.25% | 117.02% | 163.23% |
| Return on Assets (ROA) | -78.22% | 11.35% | -2.36% | -26.80% | -63.54% |
| Return on Equity (ROE) | -102.55% | 13.73% | -3.39% | -38.79% | -95.91% |
| Return on Capital Employed (ROCE) | -18.06% | -5.48% | -4.38% | -22.29% | -4.04% |
| Return on Invested Capital (ROIC) | -17.76% | -5.37% | -1.89% | -21.55% | -3.88% |
| Return on Tangible Assets | -89.10% | 15.69% | -3.35% | -39.07% | -86.58% |
| Earnings Yield | -132.35% | 21.55% | -4.06% | -53.84% | -161.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.58 | 4.71 | 5.75 | 3.24 | 3.00 |
| Payables Turnover | 5.89 | 4.34 | 6.11 | 5.13 | 8.46 |
| Inventory Turnover | 4.12 | 4.01 | 6.14 | 5.63 | 3.46 |
| Fixed Asset Turnover | 8.58 | 10.95 | 19.02 | 12.83 | 6.86 |
| Asset Turnover | 0.94 | 0.60 | 0.70 | 0.52 | 0.48 |
| Working Capital Turnover Ratio | 1.46 | 1.42 | 1.56 | 1.11 | 1.04 |
| Cash Conversion Cycle | 128.69 | 84.34 | 63.15 | 106.31 | 183.78 |
| Days of Sales Outstanding | 102.04 | 77.43 | 63.45 | 112.65 | 121.57 |
| Days of Inventory Outstanding | 88.61 | 91.00 | 59.43 | 64.85 | 105.36 |
| Days of Payables Outstanding | 61.96 | 84.09 | 59.72 | 71.20 | 43.15 |
| Operating Cycle | 190.65 | 168.43 | 122.88 | 177.51 | 226.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Free Cash Flow Per Share | -0.01 | -0.00 | 0.00 | -0.01 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -4.48 | 0.37 | 10.29 | -20.60 | -2.18 |
| Capital Expenditure Coverage Ratio | -4.48 | 0.37 | 10.29 | -20.60 | -2.18 |
| Operating Cash Flow Coverage Ratio | -9.07 | 0.24 | 4.10 | -42.59 | -8.73 |
| Operating Cash Flow to Sales Ratio | -0.16 | 0.01 | 0.06 | -0.42 | -0.38 |
| Free Cash Flow Yield | -31.51% | -1.95% | 6.78% | -46.10% | -66.94% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.76 | 4.62 | -24.64 | -1.86 | -0.62 |
| Price-to-Sales (P/S) Ratio | 0.63 | 0.87 | 0.83 | 0.95 | 0.82 |
| Price-to-Book (P/B) Ratio | 0.77 | 0.64 | 0.83 | 0.72 | 0.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.17 | -51.18 | 14.75 | -2.17 | -1.49 |
| Price-to-Operating Cash Flow Ratio | -3.88 | 87.56 | 13.32 | -2.27 | -2.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.01 | 0.27 | 0.03 | -0.00 |
| Enterprise Value Multiple | -4.82 | 1.25 | -72.43 | -0.80 | -15.17 |
| Enterprise Value | 1.89M | 2.75M | 5.29M | 2.13M | 5.80M |
| EV to EBITDA | -4.82 | 1.25 | -72.43 | -0.80 | -15.17 |
| EV to Sales | 0.27 | 0.33 | 0.54 | 0.28 | 0.68 |
| EV to Free Cash Flow | -1.36 | -19.35 | 9.65 | -0.64 | -1.23 |
| EV to Operating Cash Flow | -1.67 | 33.11 | 8.71 | -0.68 | -1.80 |
| Tangible Book Value Per Share | 0.02 | 0.03 | 0.02 | 0.02 | 0.04 |
| Shareholders’ Equity Per Share | 0.02 | 0.05 | 0.04 | 0.04 | 0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.32 | 0.00 | 0.56 | 0.02 | -0.48 |
| Revenue Per Share | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 |
| Net Income Per Share | -0.02 | 0.01 | -0.00 | -0.02 | -0.06 |
| Tax Burden | 1.32 | 1.00 | 0.44 | 1.19 | 11.93 |
| Interest Burden | 4.23 | 0.99 | 1.03 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.02 | 0.05 | 0.04 | 0.04 | 0.04 |
| SG&A to Revenue | 0.78 | 0.63 | 0.54 | 0.63 | 0.52 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 |
| Income Quality | 0.19 | 0.05 | -1.85 | 0.82 | 0.28 |
Currency in GBP
